Atlas Trials

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Clinical trial NCT03393858 · TERMINATED

Trial details

NCT number
NCT03393858
Sponsor
Capital Medical University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CancerMesothelioma, Malignant
Start date
2017-12-01
Primary completion
2021-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.